HER3 expression is linked to cell proliferation, invasion, metastasis, and poor overall survival in various cancer types, including breast[15], prostate[16], lung[17], colorectal[18], melanoma[19], ovarian[20], gastric[21], pancreatic[22], head and neck cancer[23]. This evidence concerns the gene ERBB3 and melanoma.